The Future of Cancer Diagnostics: NEXT GENERATION MOLECULAR TECHNOLOGIES

Cambridge, United Kingdom (August 21-22, 2008)

Advances in molecular diagnostics has enabled the detection of early stage tumors that will lead to greater success rates with intervention and treatment. Tests are being commercialized that employ a variety of approaches utilizing gene expression, serum biomarkers, and circulating tumors cells to capture information early for non-invasive screening of selected populations. Technologies to resolve and isolate the earliest stages of disease can be used in some cases in combination with imaging techniques to differentiate between benign vs. malignant tumors. The potential for these assays to greatly improve patient survival and care is historic and opportune and will further allow the tracking of disease progression.

More: http://www.healthtech.com/cdx/overview.aspx?c=592